InvestorsHub Logo
Followers 481
Posts 60443
Boards Moderated 18
Alias Born 09/20/2001

Re: Doc328 post# 161466

Saturday, 08/04/2018 11:29:34 AM

Saturday, August 04, 2018 11:29:34 AM

Post# of 458380
Is this a partial explanation for the Exodus of Big Pharma from CNS early this year?


HH serves as Senior Associate Editor for the Journal Alzheimer’s & Dementia; he received
lecture fees from Biogen and Roche, research grants from Pfizer, Avid, and MSD Avenir (paid to
the institution), travel funding from Axovant, Eli Lilly and company, Takeda and Zinfandel, GEHealthcare
and Oryzon Genomics, consultancy fees from Jung Diagnostics, Cytox Ltd., Axovant,
Anavex, Takeda and Zinfandel, GE Healthcare and Oryzon Genomics, and participated in scientific
advisory boards of Axovant, Eli Lilly and company, Cytox Ltd., GE Healthcare, Takeda and
Zinfandel, Oryzon Genomics and Roche Diagnostics.

and

JC has provided consultation to AbbVie, Acadia, Actinogen, Alzheon, Anavex, Avanir,
Axovant, Biogen, Boehinger-Ingelheim, Bracket, Dart, Eisai, Genentech, Kyowa, Lilly, Lundbeck,
Medavante, Merck, Orion, Otsuka, Pfizer, QR, Roche, Suven, and Takeda pharmaceutical and
assessment companies.





In Peace, In War

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News